Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP3 | P08254 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | KDM5A | P29375 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 5/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5052603 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL310173 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL6233901 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL4363976 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL5052596 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL1334842 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL4713937 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL31442966 | 0.97 | MMP1 (0.52) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL28193980 | 0.97 | MMP1 (0.52) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL17726983 | 0.93 | S1PR2 (0.53) | MMP1MMP2MMP3MMP8LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111479-A1 | FLUOROGENIC SUBSTRATES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2025-05-30 | — | — | WO | claimed |
| CN-119331478-A | Water-based heat-resistant paint, preparation method and application | 金隅微观（沧州）化工有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-107710462-B | Electrochemical hydrogen storage electrode and battery | 巴斯夫公司 | 2022-08-02 | — | — | CN | claimed |
| CN-107615556-B | Electrolyte and metal hydride battery | 巴斯夫公司 | 2021-11-02 | — | — | CN | claimed |
| US-20200283833-A1 | POLYMER TAGGED NUCLEOTIDES FOR SINGLE MOLECULE ELECTRONIC SNP ASSAY | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-09-10 | — | — | US | claimed |
| US-20180112257-A1 | POLYMER TAGGED NUCLEOTIDES FOR SINGLE MOLECULE ELECTRONIC SNP ASSAY | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2018-04-26 | — | — | US | claimed |
| CN-107922968-A | Nucleotide for the polymeric marker of unimolecule electronics SNP measure | 哥伦比亚大学董事会 | 2018-04-17 | — | — | CN | claimed |
| EP-3274471-A1 | POLYMER TAGGED NUCLEOTIDES FOR SINGLE MOLECULE ELECTRONIC SNP ASSAY | The Trustees of Columbia University in the City of New York (US) | 2018-01-31 | — | — | EP | claimed |
| WO-2016154215-A1 | POLYMER TAGGED NUCLEOTIDES FOR SINGLE MOLECULE ELECTRONIC SNP ASSAY | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-09-29 | — | — | WO | claimed |
| US-8614312-B2 | Method for preparing nucleotides and related analogues by synthesis on soluble substrate, and biological tools thus prepared | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-12-24 | — | — | US | claimed |
| US-20110118454-A1 | METHOD FOR PREPARING NUCLEOTIDES AND RELATED ANALOGUES BY SYNTHESIS ON SOLUBLE SUBSTRATE, AND BIOLOGICAL TOOLS THUS PREPARED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-05-19 | — | — | US | claimed |
| US-5990303-A | REACTING 7-DEAZA-2-DEOXY GUANOSINE WITH A PHOSPHORYLATING AGENT TO FORM NUCLEOTIDE; USED AS GUANOSINE NUCLEOTIDE ANALOGUES FOR SEQUENCE DETERMINATION; COMPOUNDS ARE STABLE AND NONAGGREGATING | ROCHE DIAGNOSTICS GMBH (DE) | 1999-11-23 | — | — | US | claimed |
| US-4565868-A | PHOSPHORYLATION, ESTERIFICATION TO PRODUCE PHOSPHATE ESTERS | SYNTEX (U.S.A.) INC. (US) | 1986-01-21 | — | — | US | claimed |
| CN-122080984-A | Borate extreme pressure agent with core-shell structure, wide-temperature-range industrial lubricating grease and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4094767-B1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4717779-A2 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TriLink BioTechnologies, LLC (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-0235301-A1 | PYRIDOPYRIMIDINE NUCLEOTIDE DERIVATIVES | TEIJIN LIMITED (JP) | 1987-09-09 | — | — | EP | disclosed |
| US-4565868-A | PHOSPHORYLATION, ESTERIFICATION TO PRODUCE PHOSPHATE ESTERS | SYNTEX (U.S.A.) INC. (US) | 1986-01-21 | — | — | US | disclosed |
| EP-0105486-A2 | 1-Monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1984-04-18 | — | — | EP | disclosed |
| US-4247328-A | TRISODIUM CITRATE, AMINE PHOSPHATES | VICKERS LIMITED (GB) | 1981-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118454-A1 | METHOD FOR PREPARING NUCLEOTIDES AND RELATED ANALOGUES BY SYNTHESIS ON SOLUBLE SUBSTRATE, AND BIOLOGICAL TOOLS THUS PREPARED | PNP, NUDT1, DUT | OPRM1 3126/4885MMP1 3916/4885MMP2 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.